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LPS promotes a monocyte 
phenotype permissive for human 
cytomegalovirus immediate-early 
gene expression upon infection but 
not reactivation from latency
V. G. Kew2, M. R. Wills2 & M. B. Reeves1
Human cytomegalovirus (HCMV) infection of myeloid cells is closely linked with the differentiation 
status of the cell. Haematopoietic progenitors and CD14+ monocytes are usually non-permissive 
for lytic gene expression which can lead to the establishment of latent infections. In contrast, 
differentiation to macrophage or dendritic cell (DC) phenotypes promotes viral reactivation or renders 
them permissive for lytic infection. The observation that high doses of Lipopolysaccharide (LPS) drove 
rapid monocyte differentiation in mice led us to investigate the response of human monocytes to 
HCMV following LPS stimulation in vitro. Here we report that LPS triggers a monocyte phenotype 
permissiveness for lytic infection directly correlating with LPS concentration. In contrast, addition 
of LPS directly to latently infected monocytes was not sufficient to trigger viral reactivation which is 
likely linked with the failure of the monocytes to differentiate to a DC phenotype. Interestingly, we 
observe that this effect on lytic infection of monocytes is transient, appears to be dependent on COX-2 
activation and does not result in a full productive infection. Thus LPS stimulated monocytes are partially 
permissive lytic gene expression but did not have long term impact on monocyte identity regarding 
their differentiation and susceptibility for the full lytic cycle of HCMV.
Primary infection with human cytomegalovirus is usually asymptomatic in the healthy host and results in the 
establishment of a lifelong latent infection. One major site of latency is the haematopoietic progenitor cell pop-
ulation resident in the bone marrow1–6. Although these cells give arise to multiple white blood cell populations 
the carriage of viral genomes is restricted to the myelo-monocytic lineage in healthy individuals3, 7, 8. Importantly, 
the differentiation of monocyte and dendritic cell (DC) precursors to a mature macrophage or DC phenotype is 
sufficient to induce lytic viral gene expression and, ultimately, result in the reactivation of infectious virus pro-
duction4, 9–12. This differentiation-dependent control of HCMV latency and reactivation is also reflected in the 
permissiveness of these same cell types for lytic infection13–17 and thus understanding the contribution of cellular 
differentiation to HCMV infection in the myeloid lineage contributes to our understanding of the factors that 
control viral infection.
First identified by Steinman and colleagues in the 1970s, DCs are a minor population of professional antigen 
presenting cells (APCs) that are able to activate primary adaptive T cell immune response18, 19. A body of liter-
ature now reports the identification and characterisation of a number of sub-populations of DCs which can be 
differentiated from each other by cell surface markers, anatomical localisation and cytokine production as well as 
mechanistic differences which has largely been based on murine studies20. The paucity of circulating DCs in the 
peripheral blood compartment has led researchers to use in vitro differentiation of CD34+ or CD14+ precur-
sors to study the function of these cells21, 22. These studies include HCMV where a number of laboratories have 
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employed the in vitro differentiation of progenitor cells to document the pivotal role cellular differentiation plays 
in latency and reactivation as well as lytic infection3, 4, 6, 11, 13, 17, 23–28.
Studies of HCMV rely largely on the long term culture of experimentally infected CD34+ or CD14+ 
cells to study viral reactivation in vitro. Importantly, a number of these experimental observations have been 
re-capitulated ex vivo through analyses of naturally latent cell types. Specifically, CD34+ cells and monocytes are 
not sites of viral reactivation1, 3, 4, 7. In contrast, DCs isolated directly ex vivo from healthy seropositives display 
evidence of lytic IE transcription and, when co-cultured with HFFs, can support HCMV reactivation12. Thus the 
models utilising in vitro differentiation of myeloid precursors to DCs can be exploited to study HCMV reactiva-
tion. However, a caveat is that whilst in vitro systems are informative they rely on relatively long term culture of 
DC populations that are then, to some degree, mapped onto the ontogeny of DCs in vivo.
However, a provocative study in the murine model pointed towards the rapid activation of circulating mono-
cytes to a DC phenotype following an endotoxin insult29. The underlying premise was to show that systemic deliv-
ery of high doses of the endotoxin lipopolysaccharide LPS generated a large expanded population of DCs within 
2–3 days in these animals. This putative DC population was hypothesised to be derived from circulating mono-
cytes consistent with monocytes retaining the capacity to differentiate into DCs in vivo. Given our own interest 
in the role of DCs in reactivation we thus asked whether human monocytes treated in vitro under the same 
conditions could trigger viral reactivation - potentially providing a rapid model for studying HCMV reactivation.
Here we report that treatment of monocytes with high concentrations of LPS prior to infection generated a cell 
type permissive for lytic immediate-early (IE) gene expression. The infection rate was LPS dose-dependent with 
higher doses resulting in increased numbers of cells being IE positive. However, unlike in DCs, the infection was 
abortive with little evidence of DNA replication or virus production evident in these cells. Furthermore, the LPS 
induced permissiveness for lytic infection was transient and was sensitive to COX-2 inhibition. In contrast, the 
stimulation of long term latently infected monocytes with LPS failed to trigger IE gene expression from latency. 
The basis for these differences could not be attributed to a global defect in the ability of latently infected monocyte 
populations to respond to LPS. These data support a hypothesis that multiple mechanisms unique to the regu-
lation of latent (but not lytic) IE gene expression need to be overcome for reactivation to ensue in differentiated 
cell types.
Results
LPS promotes monocyte permissiveness for HCMV immediate early gene expression but not 
viral replication. CD14+ monocytes were isolated from healthy seronegative donors and stimulated with 
increasing concentrations of LPS. Three days post LPS stimulation, cells were infected with the Merlin strain of 
HCMV and analysed for IE protein expression by immuno-fluorescent microscopy 24 hours post infection. At 
the highest dose of LPS clear evidence of IE protein expression was observed in the monocytes (Fig. 1A). Log 
dilutions of LPS resulted in a correlative drop in HCMV infection suggesting that high doses of LPS triggered 
monocyte differentiation to a permissive phenotype. In these first studies two things became clear: the choice of 
HCMV strain had little impact since the same phenotype in these assays was seen with the Merlin and TB40/e 
strains and thus Merlin was used throughout and, secondly, addition of 5000 ng/ml of LPS resulted in a marked 
decrease in viability over time. Consequently, our studies focused on using 500 ng/ml of LPS where the phenotype 
was clear but the increased viability would not preclude more long term analyses of viral replication.
Having addressed the effect of dose we next addressed the impact of time on permissiveness. Thus cells were 
incubated with 500 ng/ml LPS and infected at 1–3 days post stimulation (Fig. 1B). Again we observed that the 
cells were permissive for HCMV infection and, furthermore, the longer the exposure to LPS prior to infection the 
greater their permissiveness.
Throughout these initial studies it was evident that a minor proportion of cells were loosely adherent and dis-
played fewer morphological changes associated with monocyte activation/differentiation (i.e. less granular and 
fewer dendritic-like processes). Thus we performed a second analysis where both the adherent and non-adherent 
fractions were analysed independently. Following infection, the loosely adherent cells were washed off and cyto-
spun onto glass slides and stained for viral infection (Fig. 1C). As observed before, adherent LPS stimulated 
cells were permissive for HCMV infection whereas in contrast the non-adherent fraction were rarely IE positive 
(Fig. 1C) suggesting that adherence was possibly contributing to LPS-induced permissiveness. Thus to address 
whether adherence was directly important we repeated the analysis using non-adherent tubes. As before, mono-
cytes were cultured with 500 ng/ml LPS for 24 hours and then infected with HCMV all in suspension. Cells were 
harvested, cytospun briefly onto glass slides and stained for IE protein expression 24hpi (Fig. 1D). In contrast, 
to the previous analysis where the minor (<1%) non-adherent fraction did not show evidence of lytic infection 
(Fig. 1C) a bulk analysis of LPS stimulated non-adherent monocytes showed the same dose dependent permis-
siveness observed with adherent monocyte cultures (Fig. 1A). Taken together, these data suggested that a minor 
fraction of the isolated monocyte population were inherently less permissive rather than adherence being an 
important determinant per se.
To address whether the observed expression of IE proteins was abortive or resulted in the production of 
infectious virus monocytes stimulated with LPS for 3 days were infected with HCMV and then analysed with 
a gB qPCR to measure viral DNA replication. HCMV DNA replicated in HFFs resulting in a 2.5 log increase 
in viral copy number from 24 to 96 hpi with replication being sensitive to ganciclovir (Fig. 2A). In contrast, no 
evidence for viral replication was observed in monocytes or monocytes pre-treated with LPS (Fig. 2A). A defect 
in DNA replication was consistent with a single step growth curve that demonstrated cell free infectious HCMV 
virions were not detected in the supernatant of infected LPS-mono cultures (Fig. 2B). Finally, to investigate the 
possibility that the LPS monos were producing only cell associated virus we co-cultured infected cells with HFFs 
at 6 days post infection for 2 days (Fig. 2C). Again the failure to detect infectious foci in the fibroblast monolayers 
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provided further evidence that LPS stimulated monocytes were not capable of supporting the completion of the 
lytic HCMV lifecycle.
High doses of LPS do not induce IE gene expression in latently infected monocytes. A major 
research interest is to foster an understanding of the mechanisms that govern the induction of robust lytic IE 
gene expression from latently infected cells as the first stage required for HCMV reactivation. Thus we next 
tested whether induction of IE gene expression from latency was evident under culture conditions that drive 
monocyte permissiveness for lytic IE gene expression upon infection. Monocytes were infected with HCMV and 
were defined as latently infected by the concomitant detection of UL138 gene expression and minimal levels of 
major IE gene expression (Fig. 3A). These cells were then stimulated directly with 500 ng/ml LPS or, alternatively, 
with IL-4/GM-CSF to promote MoDC generation. We first analysed the induction of IE gene expression from 
latency (Fig. 3B). As expected, stimulation of immature MoDCs with LPS (50 ng/ml) was sufficient to trigger IE 
gene expression in these cells. In contrast, in monocytes not subject to prior differentiation no detectable IE gene 
expression was evident or when monocytes were incubated with LPS directly (Fig. 3B). This deficit in IE gene 
expression reflected in the level of HCMV reactivation where the co-culture of MoDCs but not LPS-monocytes 
resulted in the detection of infectious virus release into the cultures (Fig. 3C). Thus, although direct stimulation 
of monocytes with LPS was sufficient to promote permissiveness for lytic IE gene expression upon infection, it 
Figure 1. LPS promotes monocyte permissiveness in a dose dependent manner. (A) Monocytes were isolated 
from seronegative donors and incubated with mock, LPS (50–5000 ng/ml) or differentiated to DCs with IL-4/
GMCSF. At 24 hours post LPS cells were infected with Merlin and then stained for IE protein expression 24 hpi. 
Nuclei were counter-stained with DAPI and infection rate calculated. Average of 3 donors shown. *p < 0.05, 
**p < 0.01; NS = non-significant difference when compared to infection of monocyte control. (B) Monocytes 
were incubated with 500 ng/ml of LPS. They were then infected at 24, 48 and 72 hours post LPS and then stained 
for IE protein expression 24 hpi. Nuclei were counter-stained with DAPI and infection rate calculated. Average 
of 3 donors shown. (C) Monocytes were incubated with 50–5000 ng/ml of LPS for 24 hours and then infected 
with Merlin. At 24hpi non-adherent cells were aspirated and cytospun onto slides. Both fractions were then 
stained for IE protein expression 24 hpi. Nuclei were counter-stained with DAPI and infection rate calculated. 
Average of 3 donors shown. (D) Monocytes were incubated either in non-adherent tubes or on plastic with 
media alone or 500 ng/ml of LPS for 24 hours and then infected with Merlin. At 24hpi the cell suspension was 
cytospun onto slides and all samples stained for IE protein expression 24 hpi. Nuclei were counter-stained with 
DAPI and infection rate calculated. Average of 3 donors shown. NS = non-significant difference.
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was insufficient to induce lytic IE gene expression and, consequently efficiently reactivate infectious virus, from 
long term latently infected monocytes.
The secretome of latently infected monocytes does not antagonise LPS induced permissive-
ness in monocytes. The data thus far suggested that whilst LPS stimulation of monocytes rendered them 
permissive for lytic IE gene expression it was not sufficient for the induction of IE gene expression from latency. 
One possible explanation for these differences was that LPS induced effects on uninfected monocytes could occur 
through secondary messengers that are antagonised in latently infected cell cultures through modulation of the 
secretome30, 31.
We and others have shown that IL-6 – a cytokine induced by LPS – plays an important role in HCMV reacti-
vation in DCs32–34 and long term monocyte cultures35 and, furthermore, IL-6 has been shown to play a role in the 
reprogramming of differentiation in monocytes36. Thus we asked whether differential IL-6 activity could explain 
the different outcomes observed during reactivation and primary infection. The first experiments addressed 
whether the lack of detectable reactivation in the LPS monocytes was simply linked with a decrease in IL-6 pro-
duction in response to LPS stimulation and thus a reduction in paracrine signalling in the cultures. As expected, 
uninfected monocytes stimulated with LPS produced a burst of IL-6 - the levels of which decreased over time 
(Fig. 4A). An identical stimulation of latently infected monocyte cultures with LPS had no significant impact on 
the production of IL-6 in these cells over the same period of analysis (Fig. 4B) suggesting that an intrinsic fail-
ure in the capacity to generate IL-6 in the culture media could not explain a failure to reactivate in the cultures. 
Further support for many of these effects being IL-6 independent was provided by studies of permissiveness 
for lytic IE gene expression upon infection (Fig. 4C). Addition of either IL-6 or soluble IL-6 receptor to unin-
fected monocytes was not sufficient to pheno-copy the effect of LPS on monocyte susceptibility to lytic IE gene 
expression upon infection. Additionally, a neutralising antibody against IL-6 fails to reverse the ability of LPS 
to promote monocyte permissiveness for lytic IE gene expression (Fig. 4C). Taken together, the data provide no 
evidence that IL-6 plays an important role in generating the permissive phenotype nor are differences in IL-6 
production the reason for a failure of LPS to trigger IE gene expression from latency in monocytes.
Figure 2. Infection of LPS stimulated monocytes is abortive. (A) Fibroblasts (HFFs), monocytes (mono) or 
LPS stimulated monocytes (Mono LPS) were infected with Merlin and then the DNA harvested at 24 and 
96 hpi. Additionally, fibroblasts were incubated with ganciclovir (HFF GCV) at 24hpi. DNA was analysed 
in a diagnostic gB PCR to assay viral copy number n = 3. (B) Monocyte derived DCs (iDCs) or monocytes 
stimulated with 500 ng/ml LPS (Mono-LPS) were infected with Merlin (inoculum) and then samples of 
supernatants harvested every 2 days for analysis by TCID50 n = 2. (C) Monocyte derived DCs (iDC) or 
monocytes stimulated with 500 ng/ml LPS (Mono-LPS) were infected with Merlin (inoculum) and then after 
6 days transferred to monolayers of HFFs which, after 2 further days, were stained for IE positive foci and 
enumerated per well. n = 2 **p < 0.01.
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Further experiments sought to address whether the secretome from latently infected cell cultures provided 
any potential cytokine mediated inhibition of LPS activity on monocytes. Supernatants from latently infected 
monocytes were harvested and incubated with fresh uninfected monocytes isolated from the same donors. After 
48 hours monocyte cultures were stimulated with LPS and then subsequently tested their permissiveness for 
HCMV IE protein expression (Fig. 5). The data show that pre-incubation with the secretome of latently infected 
monocytes had little impact on the LPS phenotype: HCMV IE protein expression in these cells was comparable 
with control monocytes that had not been subject to prior incubation with the secretome from latently infected 
cells. Furthermore, consistent with the secretome of latently infected cells having an overt impact on the permis-
sivity of myeloid cells for HCMV infection we demonstrated that the latent secretome did not prevent HCMV 
infection of monocyte derived DCs under the same experimental conditions. Thus the data could provide no evi-
dence that the secretome from latently infected monocyte cultures contained a cytokine that blocked the ability 
of LPS to promote permissiveness for lytic IE gene expression in monocytes.
LPS promotes a distinct phenotype inconsistent with myeloid differentiation. We next consid-
ered the impact of LPS on the differentiation status of the monocytes. A comparative flow cytometric analysis 
of LPS-monocytes with unstimulated monocytes, classical MoDCs and M-CSF derived macrophages was per-
formed (Fig. 6). The data clearly show that LPS does not induce a phenotype consistent with differentiation to a 
DC, evidenced by a lack of DC-SIGN expression or CD86 and HLA-DR upregulation, and the sustained expres-
sion of CD14. Interestingly, unlike M-CSF macrophages and DCs, addition of LPS directly to the monocytes 
promoted a dramatic loss of CD11b again suggesting a unique response. Furthermore, LPS monocytes expressed 
no detectable CD80, similar to monocytes, whereas the macrophages and DCs expressed, albeit modest, levels of 
CD80. Taken together, the phenotypic data provide no evidence to suggest that LPS was driving a more differen-
tiated monocytes but, instead, bore more hallmarks of unstimulated monocytes in culture.
The ability of LPS to generate a permissive environment for IE gene expression can be 
reversed. To further understand the differences we observed between lytic infection and HCMV reactivation 
Figure 3. LPS does not induce IE gene expression in latently infected monocytes. (A) Monocytes were infected 
with Merlin and 3 dpi analysed for UL138 and UL123 expression by qRT-PCR and then calculated relative 
to GAPDH control. RNA without prior RT was analysed concurrently (no RT) n = 3. (B) Latently infected 
monocytes were either treated with media alone (mono), 50–5000 ng/ml LPS (Mono + LPS) or differentiated 
with IL-4/GM-CSF and then stimulated with 50 ng/ml LPS (iDC + LPS). Eight hours post stimulation, RNA 
was harvested and analysed for UL123 (MIE) gene expression and expressed relative to GAPDH. RNA without 
prior RT was analysed concurrently (no RT) n = 3. **p < 0.01; NS = non-significant difference when compared 
to monocyte control. (C) Latently infected monocytes were either treated with media alone (mono), 500 ng/ml 
LPS (Mono + LPS) or differentiated with IL-4/GM-CSF and then stimulated with 50 ng/ml LPS (iDC + LPS). 
Cells were then co-cultured with fibroblasts for 17 days which were stained for IE protein expression to identify 
infectious centres n = 3. **p < 0.01; NS = non-significant difference when compared to monocyte control.
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in these analyses we next asked whether the LPS effect on monocyte susceptibility to lytic gene expression was 
permanent. The cell surface phenotyping suggested that LPS was not driving cellular differentiation based on the 
expression of a panel of cell surface markers that are known to be associated with classical DC differentiation. 
Also consistent with a lack of differentiation, was a failure to detect any evidence of viral reactivation from latency 
since, in a number of latency models, differentiation is a key determinant of reactivation. We hypothesised, there-
fore, that LPS could be promoting a priming event that is supportive of some lytic gene expression upon de novo 
infection. To test this, monocytes were incubated with 500 ng/ml LPS for 72 hours or, alternatively, incubated 
with LPS for 24 hours and then rescued in fresh media (48 hours) after multiple washes. At the 72 hour time point, 
the cells were then infected with HCMV and immuno-stained for IE gene expression (Fig. 7A). Unstimulated 
monocytes remained non-permissive for lytic IE gene expression whereas long term exposure to LPS permitted 
IE protein expression (Fig. 7A). Interestingly, short term exposure to LPS followed by a resuscitation period 
resulted in substantially fewer monocytes being permissive for lytic infection although some infection remained 
(Fig. 7A). This failure to initiate IE gene expression was not linked with an intrinsic block to viral entry. A PCR 
analysis of the cell DNA revealed similar levels of viral DNA in washed and unwashed LPS stimulated monocytes 
at 24 hours post infection (Fig. 7B).
A possible explanation for these transient effects was the hyper-activation of intracellular pathways that con-
tribute to lytic infection during the initial stages of viral infection but are not capable of reversing viral latency. To 
investigate this further we tested the ability of a panel of inhibitors to block the LPS mediated effect on monocytes 
we had observed. Using inhibitors of downstream signalling pathways reported to be LPS responsive in various 
cell culture models we detected that the LPS induced phenotype was most potently inhibited by the COX-2 
inhibitor, indomethacin (Fig. 8A). This COX-2 inhibitor phenotype was specific to LPS stimulated monocytes 
since pre-treatment of fully permissive cells with indomethacin had little impact on IE gene expression (Fig. 8B).
Figure 4. The differential effects of LPS are independent of IL-6 activity. (A) The supernatants from monocytes 
at 0, 3, 6 and 24 hours post LPS (500 ng/ml) stimulation were harvested and analysed for IL-6 production 
by ELISA n = 2. (B) The supernatants from uninfected monocytes (mono) or long term latently infected 
monocytes (Mono + HCMV) at 0, 3, 6 and 24 hours post LPS (500 ng/ml) stimulation were harvested and 
analysed for IL-6 production by ELISA n = 2. (C) Monocytes were stimulated with 500 ng/ml LPS, 50 ug/ml 
IL6, 500 ng/ml LPS plus nIL6 antibody, or 50 ug/ml soluble IL6 receptor (sIL6r) for 24 hours then infected with 
Merlin and then stained for IE protein expression 24 hpi. Nuclei were counter-stained with DAPI and infection 
rate calculated n = 3. **p < 0.01; NS = non-significant difference when compared to infection of LPS control.
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Discussion
Permissiveness for lytic infection or for the reactivation of HCMV from latency in the myeloid lineage is inti-
mately associated with the differentiation status of the cell24. In this study, we sought to address whether high 
doses of LPS could render normally non-permissive monocytes permissive for HCMV infection and reactiva-
tion. The rationale for this approach was driven by a previous study in the murine system which showed that 
circulating monocytes rapidly populated the DC pool in response to high concentrations of LPS29 – potentially 
representing a new, quicker approach to study HCMV reactivation in vitro.
The observation that high doses of LPS made normally non-permissive monocytes permissive for IE lytic 
gene expression led us to investigate further. However, the effects appeared to be transitory and much of the 
subsequent data argued against these cells being fully differentiated DCs in vitro. A caveat of initial analyses was 
the identification of a sub-population of ‘monocytes’ that appeared resistant to HCMV infection even if treated 
with LPS (Fig. 1). One possibility is that these are contaminating cell type and these cells were not analysed for 
CD14+ expression and no monocyte preparation will ever be 100% pure. However, an intriguing aspect was that 
an analysis by RT-PCR revealed that UL138 gene expression, but not UL123, could be detected. Thus this minor 
fraction could be infected but appeared to favour a latent infection phenotype.
Consistent with the infection data, phenotypic analyses suggested that although the specific changes in cell 
surface markers were evident the changes did not reflect a phenotype that could be described as a classical DC. 
Furthermore, the LPS stimulated monocytes, unlike classical DCs, did not support the production of new infec-
tious particles arguing that an abortive infection was taking place. Finally, again consistent with an overt lack 
of differentiation, the addition of LPS to latently infected monocytes was not sufficient to promote reactivation. 
Related to the studies of HCMV reactivation we accept that in our supernatant experiments we cannot rule out 
the possibility that that latently infected cells are inherently less responsive to LPS since not all the cells within the 
population will be harbouring viral genomes. Thus although we could induce IL-6 in cultures of latently infected 
monocytes using LPS we cannot rule out that these effects are restricted to uninfected cells and that LPS (or IL-6) 
signalling is impaired in undifferentiated latently infected cells.
Central to our own research interests was the observation that the treatment of monocytes with LPS failed to 
trigger IE gene expression in latently infected cells. This clearly suggested that an intrinsic block to reactivation 
was not relieved under these differentiation/activation conditions in contrast to when the cells are incubated with 
IL-4/GM-CSF to make classical DCs4, 32. What this suggests is that the mechanisms governing the maintenance of 
long term latency are not wholly equivalent to the mechanisms important during the initial stages of infection in 
non-permissive cells. The mechanisms dictating long term latency are likely a concert of viral and cellular factors 
that promote the long term repression of lytic gene expression via the utilisation of histone modifying enzymes, 
chromatin structure, miRNA function and re-partitioning of cell signalling pathways4, 37–43. In contrast, during 
those initial stages the intrinsic hostile cellular environment the virus encounters – and likely a failure to over-
come that - is the major determinant44, 45. Consequently, studying the basis of why the addition of LPS to latently 
infected monocytes does not drive viral reactivation can contribute to defining the mechanisms that do.
Why high doses of LPS makes monocytes permissive for IE gene expression is also an interesting question. It 
potentially could also explain studies which have suggested that monocytes and myeloid cells display a level of 
Figure 5. The supernatant of latently infected monocytes does not prevent LPS mediated effects on uninfected 
monocytes. To generate a latent secretome monocytes were infected with HCMV and cell free conditioned 
media harvested at 7dpi (s/n). Fresh monocytes were either incubated with normal (mono) or conditioned 
(mock + s/n) media for 48 hours. A fraction of the cells from both conditions were then further stimulated with 
(500 ng/ml LPS for 24 hours). Alternatively, uninfected monocytes were differentiated to permissive dendritic 
cells and incubated with normal media (iDC) or supernatant from latently infected monocytes (iDC + s/n) 
again for 48 hours. All cells were then infected with Merlin 2 days post incubation with mock or conditioned 
media and stained for IE protein expression 24 hpi. Nuclei were counter-stained with DAPI and infection 
rate calculated n = 3. NS = non-significant difference when comparing infection rates between mock and 
conditioned media treated cells.
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permissiveness for HCMV infection under certain conditions46–48. LPS is recognised by the pattern recognition 
receptor TLR4 which then signals downstream through multiple pathways49. HCMV has also been shown to bind 
and engage with TLRs – notably TLR250 – but also TLR4 in monocytic cells51. Potentially, infecting monocytes 
at high MOIs may substitute for the LPS effects here and render monocytes transiently permissive for IE gene 
expression through delivery of high numbers of viral particles activating TLR4. It is possible that such a scenario 
could occur during viraemia and thus could represent a host response that is advantageous. The abortive expres-
sion of IE proteins in an absence of the expression of key immune evasion genes could facilitate a more effective T 
cell immune response and promote elimination of infected cells. It is this principle of inducing abortive IE protein 
expression that underpins the strategy of the use of HDAC inhibitors to clear latently infected cells52.
Alternatively, the addition of LPS could be impacting on the normal entry pathways active in the monocyte. 
Studies, mainly from the Yurochko laboratory, implicate the presence of a unique entry pathway into mono-
cytes53–56. Most recently, they report that the HCMV genome can take upwards of 3 days to enter the nucleus55. 
Clearly, in these studies we are observing IE protein expression by 24 hours post infection and thus it is possible 
LPS is activating the cells to respond differently to infection circumventing this delayed pathway. Indeed, our 
observation that the LPS effect is COX-2 dependent in the monocytes may be linked to this. It has been previ-
ously described that COX-2 plays an important role in the replication and pathogenesis of CMV during lytic 
infection57–59. However, the major impact in fully permissive fibroblasts is on the switch from IE72 to IE86 protein 
expression and, ultimately, the production of new virions58. Thus during lytic replication COX-2 activation plays a 
key role during the later stages of viral infection and, importantly, post- IE and therefore cannot be directly related 
to the LPS effects we are reporting. However, a less well explored role of COX-2 is the potential of this pathway to 
impact on endocytosis and virus infection60. HCMV has evolved to utilise multiple entry pathways61 and thus the 
priming events we see with LPS may reflect a change in the pathway utilisation of HCMV due to hyper-activation 
of a COX-2 sensitive endocytic pathway in the monocytes. Although highly speculative, entry via this route 
Figure 6. Incubation of monocytes with LPS promotes a unique phenotype. CD14+ monocytes were isolated 
by magnetic cell separation using CD14 beads from PBMC. Monocytes were incubated in media or stimulated 
with 500 ng/ml LPS for 1 and 3 days, IL4/GMCSF or MCSF for 6 days. Post incubation, monocytes were 
stained with cell surface antibodies to various phenotypic markers (CD14, CD83, CD86, CCR5, MHC Class II 
(HLA-DR), CD11b, CD209 (DC-SIGN), MHC Class I, CD80 or appropriate Isotype controls. Flow cytometry 
histogram plots against isotype controls for each treatment condition and phenotypic marker are shown.
www.nature.com/scientificreports/
9Scientific RepoRts | 7: 810  | DOI:10.1038/s41598-017-00999-8
may circumvent the usual entry pathway allowing the (potentially aberrant) initiation of viral gene expression. 
However, a post-IE block remains active in normally non-permissive cells and thus the virus does not continue 
into a full productive infection. An alternative, but linked, explanation may involve the delivery of tegument. A 
contributing factor to latent infection has been hypothesised to be the failure to deliver the major virion transacti-
vator, pp71, to the nucleus in non-permissive myeloid cells62. Thus an equally plausible explanation could be that 
pp71 does traffic to the nucleus if the cells are primed with LPS.
Here we report the transient induction of a cellular environment in monocytes by LPS that supports IE lytic 
gene expression upon infection. In contrast, the effects of LPS on latent HCMV in monocytes is minimal sug-
gesting that LPS fails to overcome additional blocks controlling IE gene expression during latency in monocytes. 
Understanding the molecular basis for these differences could enhance our understanding of the mechanisms 
Figure 7. The LPS induced permissiveness of monocytes is transient. (A) Monocytes (monos) were either 
differentiated to dendritic cells (iDCs), stimulated with 500 ng/ml LPS for 72 hours (mono-LPS) or stimulated 
with LPS for 24 hours and then washed for 48 hours. Cells were then infected with Merlin and stained for 
IE protein expression 24 hpi. Nuclei were counter-stained with DAPI and infection rate calculated n = 3. 
(B) Monocytes were stimulated with 500 ng/ml LPS and then either incubated for 72 hours (Mono-LPS) or 
incubated for 24 hours followed by 48 hours in media alone (Mono LPS washed). DNA was then harvested and 
amplified in a diagnostic qPCR against gB with copy number normalised to cell number using a beta globin 
PCR n = 3. **p < 0.01 comparing infection in LPS and LPS-washed cells.
Figure 8. A COX-2 inhibitor antagonises LPS mediated permissiveness of monocytes. (A) Monocytes were 
incubated with control (DMSO), or inhibitors of ERK, COX2, p38 or JNK for 4 hours prior to addition of LPS 
(500 ng/ml). After 24 hours, cells were then infected with Merlin and stained for IE protein expression 24hpi. 
Nuclei were counter-stained with DAPI and infection rate calculated n = 3. **p < 0.01; NS = non-significant 
difference when compared to infection of DMSO solvent control. (B) HFFs, monocyte derived dendritic cells 
(DCs) or epithelial cells (ARPE) were pre-treated with DMSO or a COX-2 inhibitor for 4 hours then infected 
with Merlin and stained for IE protein expression 24hpi. Nuclei were counter-stained with DAPI and infection 
rate calculated n = 3. NS = non-significant difference when comparing rate of infection of each cell type plus 
and minus inhibitor.
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governing HCMV reactivation. Importantly, we report that high doses of LPS in vitro do not appear to support 
the generation of a DC phenotype which is supported by both phenotypic evidence and, indirectly, the failure of 
HCMV to replicate in these cells. Therefore it is likely that LPS acts in concert with other cytokines in vivo to drive 
the DC phenotype observed in the murine model.
Materials and Methods
Ethical statement. All studies on monocytes were performed with local approval from either the Cambridge 
or UCL Local Research Ethics Committee and all experiments were performed under the guidelines and regu-
lations set out by the committees. Informed consent was given locally unless excess material from NHS Blood 
Transfusion Service (Colindale, UK) was used where donors provide consent at point of donation for material to 
be used anonymously in research studies.
Cells, tissue culture, cytokines and inhibitors. Human foreskin fibroblasts (HFFs) were maintained in 
Dulbecco’s minimal essential medium containing 10% fetal calf serum (DMEM-10) (GIBCO, UK) and incubated 
at 37 °C and in 5% CO2. CD14+ mononuclear cells were directly isolated from HCMV-seronegative blood and 
immature DCs were generated as described previously. Briefly, peripheral blood mononuclear cells (PBMCs) were 
prepared by centrifugation on a Ficoll-Hypaque (Lymphoprep; Takeda, UK) density gradient. Magnetic-activated 
cell sorting using CD14+ antibody-conjugated MicroBeads (Miltenyi Biotec, Surrey, UK) allowed collection of a 
CD14+ mononuclear cell-enriched population, which were maintained in X-VIVO 15 serum free media (Lonza, 
Walkersville, MD, USA). To promote differentiation to a MoDC phenotype, cultures were stimulated with IL-4 
(100 ng/ml) and GM-CSF (100 ng/ml) for 6 days (both cytokines Peprotech, Rocky Hill, NJ). Loosely adherent 
cells were collected by moderate aspiration and transferred to fresh wells. Mature DCs were generated by adding 
LPS in fresh media (50 ng/ml; Sigma-Aldrich, Poole, UK).
Alternatively, monocytes were incubated directly with LPS (50–5000 ng/ml) for 1–3 days with no prior dif-
ferentiation as described in the results. For experiments analyzing IL-6 activity, IL-6 (Peprotech, Rocky Hill, NJ; 
500 ng/ml) and neutralizing IL6 antibody (R&D Systems, Minneapolis, MN; 10 ug/ml) were used at concentra-
tions previously shown to have activity in HCMV reactivation32. The soluble IL6 receptor (Peprotech, Rocky Hill, 
NJ; 50 ng/ml) was used at an equivalent concentration to IL-6.
To measure IL-6 in the culture medium an IL-6 ELISA quantikine kit was used as described by manufacturer 
(R&D Systems, Minneapolis, MN).
The following inhibitors all Calbiochem (Merck, Darmstadt, Germany) unless stated were used at concen-
trations known to inhibit activity of their target. ERK (U0126;10 uM), JNK (SP600125; 5 uM), p38 (SB203580; 
5 uM) and COX-2 (indomethacin; 1 uM; VWR international, Leicester, UK) were added to media 1 hour prior 
to stimulation with LPS and/or subsequent infection with HCMV. Ganciclovir (SIGMA, Poole, UK) was used at 
10 ug/ml to inhibit viral DNA replication.
To culture TB40/e and Merlin strains of HCMV they were first cultured in ARPE-19 cells and then amplified 
following a single round of replication in HFFs. Virus was isolated and purified on sorbitol gradients as described 
previously63.
For DNA replication analysis experiments, infected monocytes were washed in PBS and then incubated for 
1 hour with 2 mg/ml Proteinase K solution and the media replaced with fresh media to remove un-internalised 
virus from the cell surface.
Latency establishment and co-culture experiments. To study latency CD14+ monocytes were cul-
tured for at least 4 hours in X-vivo 15 following isolation and then infected with a preparation of the clinical 
isolate Merlin (MOI = 5 on fibroblasts; MOI = 0.1 in DCs). After 3 hours, infected cells are washed and cultured 
in fresh X-vivo 15 media for 7 days. After 3 days, media is exchanged again and fresh media containing cytokines 
that promote DC differentiation are added as described before. Virus production from reactivating mature 
MoDCs or from LPS stimulated monocytes was assayed by IE qRT-PCR 24 hours post stimulation or after follow-
ing co-culture on a confluent monolayer of HFF with samples of supernatant taken at regular intervals and used 
to inoculate fresh HFF to test for infectious virus by indirect immuno-fluorescent staining.
Indirect immunofluorescence and Western blotting. Infected cells were rinsed in PBS and fixed for 
10 minutes in 4% paraformaldehyde at room temperature. After permeabilizing with 0.1% Triton-X-100 in PBS, 
cells were incubated with monoclonal mouse anti-IE antibody (Millipore) (1:1000 dilution in PBS) for 1 hour 
at room temperature. After washing with PBS, the bound antibodies were detected using Alexafluor 594 nm 
(Millipore, Billerica, MA)-conjugated goat anti-mouse immunoglobulins (1:1000 dilution in PBS) together with 
nuclear stain DAPI (300 nM in PBS) in the dark for 1 hour at room temperature. After washing with PBS, infected 
cells were visualised using a Nikon immunofluorescence microscope and were quantified using ImagePro WCIF 
ImageJ software (National Institutes of Health). Percentage infection was calculated by dividing the number of 
infected cells (red) by the total number of cells (blue) from at least 4 fields of view.
Nucleic Acid Isolation and Analysis. Total RNA was extracted from 106 cells using the RNAeasy kit as 
described by the manufacturer (Qiagen, Sussex, UK) Residual genomic DNA was removed by a DNAse I diges-
tion (Promega, Madison, WI) followed by production of first-strand cDNA using the Promega RT system. For 
quantitative PCR, primers that amplified the IE region of HCMV were used64. The following reaction conditions 
were used in a 96 well plate format with forward primer AGC GCC GCA TTG AGG A, reverse primer CAG 
ACT CTC AGA GGA TCG GCC and probe ATC TGC ATG AAG GTC TTT GCC CAG TAC ATT (Fam probe 
with TAMRA quencher). PCR reactions were performed using Taqman MasterMix (Applied Biosystems, Foster 
City, CA) in a 7500HT machine (Applied Biosystems, Foster City, CA). Actin was amplified using a VIC-actin 
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commercial probe (Applied Biosystems, Foster City, CA) and statistical analysis and interpretation performed as 
described65.
To assay DNA replication, total DNA was isolated using a sodium perchlorate method described previously 
which has been optimized for the isolation and detection of viral genomes from naturally latent mononuclear 
cells (23). Briefly, 106 cells were resuspended in 600 ul of buffer A (100 mM NaCl, 5 mM; pH 8.0), lysed with 10% 
SDS (125 ul) and then incubated with 5 M sodium percholorate (150 ul). DNA was isolated by phenol:chloroform 
extraction and isopropanol precipitation. DNA copy number was then quantified using gB qPCR used in diag-
nostic assays66.
Cell surface phenotype flow cytometry analysis. Monocyte at 106 cells/ml were suspended in X-vivo 
15 media in capped polypropylene FACS tubes (BD) pulsed with LPS, IL-4/GM-CSF to generate DCs or, 20 ng/
ml M-CSF (Miltenyi Biotec, Surrey, UK) for 1, 3 or 6 days incubated at 37 °C 5% CO2. Cells were pelleted at 
400 g for 5 minutes and 105 cells per staining condition were stained with monoclonal antibodies specific for 
CD14-APC, CD83-APC, CD86-PE, CCR5-APC, MHC Class II (HLA-DR)-APC from BD Pharmingen (Oxford, 
UK), CD11b-FITC, CD209 (DC-SIGN)-PE, MHC Class I-PE from BioLegend (San Diego, CA) and CD80-APC 
from Abcam (Cambridge, UK). Isotype controls IgG1-FITC, IgG1-APC, IgG2a-PE, IgG2a-APC in the dark at 
room temperature for 30 mins.
Following washing in PBS, the cells were pelleted at 400 g for 5 minutes and were re-suspended in 500 μl of 
phosphate buffered saline (PBS) before analyzing by flow cytometry (BD AccuriC6). Data handling was per-
formed using AccuriC6 and FLOWJO software.
Statistical Analyses. Tests for statistical significance were performed using the non-parametric Mann 
Whitney U test on paired samples. Statistical significance was designated for any p value lower than 0.05.
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